Tampere University Hospital is a teaching hospital of Tampere University along Teiskontie at the Kauppi district in Tampere, Finland.

There are 1,000 beds in Tampere University Hospital; Dept of Oncology.

During the past decade, Tampere University Hospital; Dept of Oncology conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 7 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tampere University Hospital; Dept of Oncology" #1 collaborator was "Foundation Medicine, Inc." with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Tampere University Hospital; Dept of Oncology" are "Metastatic Breast Cancer" (2 trials), "Breast Cancer" (1 trials), "Breast Neoplasms" (1 trials), "Cancer of Unknown Primary Site" (1 trials) and "Colorectal Cancer" (1 trials). Many other conditions were trialed in "Tampere University Hospital; Dept of Oncology" in a lesser frequency.

Most popular intervention types in "Tampere University Hospital; Dept of Oncology" are "Drug" (14 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (4 trials), "Placebo" (4 trials), "Docetaxel" (3 trials), "Gemcitabine" (3 trials) and "Pertuzumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Tampere University Hospital; Dept of Oncology" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Tampere University Hospital; Dept of Oncology". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Tampere University Hospital; Dept of Oncology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Tampere University Hospital; Dept of Oncology, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".